Triple-negative breast cancer is a particularly aggressive form of the disease with no specific treatment. In a new study led by the University of Pennsylvania’s Rumela Chakrabarti, researchers discovered that, in contrast to many other cancer types, activation of the interferon gamma signaling contributes to disease progression and spread. The findings may help doctors choose a personalized treatment strategy for triple-negative breast cancer patients, depending on their cancer subtype.
- Gall fly outmaneuvers host plant in game of “Spy vs. Spy”
- Black individuals at higher risk for contracting COVID-19, according to new research
- Chatbots can ease medical providers’ burden, offer guidance to those with COVID-19 symptoms
- Using electricity to break down pollutants left over after wastewater treatment
- Extreme rainfall events cause top-heavy aquatic food webs